Meanwhile, a judge has ruled that Illumina's $7.1 billion purchase of Bay Area cancer detector Grail can move ahead despite the FTC's attempt to block it.
Meanwhile, a judge has ruled that Illumina's $7.1 billion purchase of Bay Area cancer detector Grail can move ahead despite the FTC's attempt to block it.
